The importance of the aplication long-therm therapy (LTOT) in COPD tretmant

Z. Radulovic, A. Toljic, M. R. Medenica (Niksic, Serbia And Montenegro)

Source: Annual Congress 2006 - Oxygen therapy
Session: Oxygen therapy
Session type: Electronic Poster Session
Number: 2988
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Z. Radulovic, A. Toljic, M. R. Medenica (Niksic, Serbia And Montenegro). The importance of the aplication long-therm therapy (LTOT) in COPD tretmant. Eur Respir J 2006; 28: Suppl. 50, 2988

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Poor compliance with guidelines for prescription of long-term oxygen therapy (LTOT) in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2010 - Palliative care, oxygen and community care for chronic lung disease
Year: 2010


Hospital treatment costs of exacerbations in COPD patients with indications for LTOT
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015


Long-term oxygen therapy (LTOT) in COPD improves patients' health status
Source: Annual Congress 2003 - Intervention strategies in chronic respiratory failure
Year: 2003


International approaches to the prescription of long-term oxygen therapy (LTOT)
Source: Eur Respir J 2001; 18: Suppl. 33, 489s
Year: 2001

Physician compliance with long-term oxygen therapy (LTOT) guidelines
Source: Eur Respir J 2003; 22: Suppl. 45, 423s
Year: 2003

Liquid long-term oxygen therapy (LTOT) improves health status in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 709s
Year: 2005

Quality of life in patients with chronic obstructive pulmonary disease (COPD) and long-term oxygen therapy (LTOT)
Source: Eur Respir J 2001; 18: Suppl. 33, 486s
Year: 2001

The healthcare burden of non-compliance to pharmacotherapeutic escalation recommendations for COPD
Source: International Congress 2016 – Pharmacological management of COPD
Year: 2016


Effectiveness of pulmonary rehabilitation including occupational therapy (OT) on the prognosis of patients with COPD
Source: Annual Congress 2012 - New adjuncts and modalities in pulmonary rehabilitation
Year: 2012


Our experience of 200 patients: Usage and maintenance of long-term oxygen therapy and non-invasive ventilation devices at home
Source: Annual Congress 2013 –Long-term NIV: COPD, sleep, obesity and outcomes
Year: 2013

Inhaled corticosteroids and survival in patients with COPD receiving long-term home oxygen therapy
Source: Annual Congress 2005 - Effects of anti-inflammatory drugs on COPD
Year: 2005


Cost consequences of tiotropium plus existing therapy versus existing therapy alone following one year of treatment in patients with COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 5s
Year: 2001

Usefulness and impact of an educational programme (EP) on long term oxygen therapy (LTOT) prescriptions
Source: Annual Congress 2009 - Oxygen, end-of-life and care for chronic respiratory patients
Year: 2009

Nonmedical therapy for COPD
Source: Annual Congress 2012 - PG9 Progress on the treatment of COPD
Year: 2012



Characterization of physical activity (PA) patterns by use of multiple accelerometers in COPD patients undergoing long-term oxygen therapy (LTOT) within a pulmonary rehabilitation (PR) program
Source: Annual Congress 2010 - Physical activity, exercise regimes and outcomes for chronic respiratory disease
Year: 2010


Patients’ perception on long-term domiciliary oxygen therapy
Source: International Congress 2015 – Kaleidoscope of nursing research
Year: 2015


Long-term oxygen therapy (LTOT) at home for patients with chronic respiratory failure (CRF)
Source: Eur Respir J 2003; 22: Suppl. 45, 241s
Year: 2003

CAT predicts mortality in COPD patients who require LTOT
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016


Prescribing patterns for UK patients commencing first maintenance therapy for COPD
Source: International Congress 2014 – COPD markers
Year: 2014


Real-life evaluation of budesonide/formoterol (DuoResp Spiromax) for the management of asthma and COPD in the UK
Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD
Year: 2017